Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09).
Oncology
; 89(2): 70-8, 2015.
Article
in En
| MEDLINE
| ID: mdl-25765871
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urologic Neoplasms
/
Paclitaxel
/
Urothelium
/
Everolimus
/
Antineoplastic Agents
Type of study:
Clinical_trials
Aspects:
Patient_preference
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Oncology
Year:
2015
Document type:
Article
Affiliation country:
Germany
Country of publication:
Switzerland